These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 30992569)

  • 1. Towards individualized therapy for metastatic renal cell carcinoma.
    Kotecha RR; Motzer RJ; Voss MH
    Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel biomarkers in renal cell carcinoma. Identification and functional characterization].
    Macher-Göppinger S
    Pathologe; 2015 Nov; 36 Suppl 2():201-4. PubMed ID: 26362327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
    Sanfrancesco JM; Cheng L
    Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
    Donskov F; Heng DY; Rini BI
    Expert Rev Anticancer Ther; 2017 Feb; 17(2):97-99. PubMed ID: 27927054
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalised medicine in renal cell tumours].
    Junker K; Zeuschner P
    Aktuelle Urol; 2019 Sep; 50(5):513-523. PubMed ID: 31167243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies for renal cell carcinoma.
    Posadas EM; Limvorasak S; Figlin RA
    Nat Rev Nephrol; 2017 Aug; 13(8):496-511. PubMed ID: 28691713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Management of Advanced Kidney Cancer.
    Graham J; Heng DYC; Brugarolas J; Vaishampayan U
    Am Soc Clin Oncol Educ Book; 2018 May; 38():330-341. PubMed ID: 30231375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
    Bex A; Gore M; Mulders P; Sternberg CN
    BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options.
    Bellmunt J; Eisen T; Szczylik C; Mulders P; Porta C
    BJU Int; 2011 Apr; 107(8):1190-9. PubMed ID: 21078050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.
    Vuong L; Kotecha RR; Voss MH; Hakimi AA
    Cancer Discov; 2019 Oct; 9(10):1349-1357. PubMed ID: 31527133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics of renal cell cancer: the biology behind and the therapy ahead.
    Jones J; Libermann TA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry.
    Goebell PJ; Staehler M; Müller L; Nusch A; Scheffler M; Sauer A; von Verschuer U; Tech S; Kruggel L; Jänicke M; Marschner N;
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1101-e1115. PubMed ID: 30061035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of cytoreductive nephrectomy in patients with renal cell carcinoma.
    Ghandour RA; Singla N; Margulis V
    Expert Rev Anticancer Ther; 2019 May; 19(5):405-411. PubMed ID: 31020871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular-based therapies for renal cell carcinoma.
    Zisman A; Pantuck AJ; Belldegrun AS
    Curr Urol Rep; 2001 Feb; 2(1):55-61. PubMed ID: 12084296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for advanced renal cell carcinoma.
    Meissner MA; McCormick BZ; Karam JA; Wood CG
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):663-671. PubMed ID: 29707987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of prognostic factors in patients with metastatic renal cell carcinoma.
    Teishima J; Inoue S; Hayashi T; Matsubara A
    Int J Urol; 2019 Jun; 26(6):608-617. PubMed ID: 30959579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.